Literature DB >> 20412390

An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42.

Ioannis Dafnis1, Efstratios Stratikos, Athina Tzinia, Effie C Tsilibary, Vassilis I Zannis, Angeliki Chroni.   

Abstract

Apolipoprotein E (apoE) plays a crucial role in lipid transport in circulation and the brain. The apoE4 isoform is a major risk factor for Alzheimer's disease (AD). ApoE4 is more susceptible to proteolysis than other apoE isoforms and apoE4 fragments have been found in brains of AD patients. These apoE4 fragments have been hypothesized to be involved in the pathogenesis of AD, although the mechanism is not clear. In this study we examined the effect of lipid-free apoE4 on amyloid precursor protein processing and 40-amino-acid Aβ variant and 42-amino-acid Aβ variant levels in human neuroblastoma SK-N-SH cells. We discovered that a specific apoE4 fragment, apoE4[Δ(166-299)], can promote the cellular uptake of extracellular 40-amino-acid Aβ variant and 42-amino-acid Aβ variant either generated after amyloid precursor protein transfection or added exogenously. A longer length fragment, apoE4[Δ(186-299)], or full-length apoE4 failed to elicit this effect. ApoE4[Δ(166-299)] effected a 20% reduction of cellular sphingomyelin levels, as well as changes in cellular membrane micro-fluidity. Following uptake, approximately 50% of 42-amino-acid Aβ variant remained within the cell for at least 24 h, and led to increased formation of reactive oxygen species. Overall, our findings suggest a direct link between two early events in the pathogenesis of AD, apoE4 proteolysis and intraneuronal presence of amyloid beta peptide.
© 2010 The Authors. Journal Compilation © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412390      PMCID: PMC2910182          DOI: 10.1111/j.1471-4159.2010.06756.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  48 in total

1.  ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain.

Authors:  Veera Venkata Ratnam Bandaru; Juan Troncoso; David Wheeler; Olga Pletnikova; Jessica Wang; Kathy Conant; Norman J Haughey
Journal:  Neurobiol Aging       Date:  2007-09-20       Impact factor: 4.673

2.  Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties.

Authors:  Angeliki Chroni; Serapion Pyrpassopoulos; Angelos Thanassoulas; George Nounesis; Vassilis I Zannis; Efstratios Stratikos
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

3.  Platelet beta-secretase activity is increased in Alzheimer's disease.

Authors:  J A Johnston; W W Liu; D T R Coulson; S Todd; S Murphy; S Brennan; C J Foy; D Craig; G B Irvine; A P Passmore
Journal:  Neurobiol Aging       Date:  2006-12-14       Impact factor: 4.673

4.  Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice.

Authors:  Celina V Zerbinatti; Suzanne E Wahrle; Hyungjin Kim; Judy A Cam; Kelly Bales; Steven M Paul; David M Holtzman; Guojun Bu
Journal:  J Biol Chem       Date:  2006-09-29       Impact factor: 5.157

Review 5.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 6.  The redox chemistry of the Alzheimer's disease amyloid beta peptide.

Authors:  Danielle G Smith; Roberto Cappai; Kevin J Barnham
Journal:  Biochim Biophys Acta       Date:  2007-02-09

7.  Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E.

Authors:  Lucila Saavedra; Amany Mohamed; Victoria Ma; Satyabrata Kar; Elena Posse de Chaves
Journal:  J Biol Chem       Date:  2007-10-02       Impact factor: 5.157

Review 8.  Intracellular amyloid-beta in Alzheimer's disease.

Authors:  Frank M LaFerla; Kim N Green; Salvatore Oddo
Journal:  Nat Rev Neurosci       Date:  2007-07       Impact factor: 34.870

Review 9.  Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment.

Authors:  T A Bayer; O Wirths
Journal:  Genes Brain Behav       Date:  2008-02       Impact factor: 3.449

10.  Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein.

Authors:  Karunya K Kandimalla; Olenych G Scott; Smita Fulzele; Michael W Davidson; Joseph F Poduslo
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more
  16 in total

Review 1.  Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.

Authors:  Evan Dorey; Nina Chang; Qing Yan Liu; Ze Yang; Wandong Zhang
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

2.  An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines.

Authors:  I Dafnis; A K Tzinia; E C Tsilibary; V I Zannis; A Chroni
Journal:  Neuroscience       Date:  2012-03-14       Impact factor: 3.590

3.  Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4.

Authors:  Letta Argyri; Ioannis Dafnis; Theodossis A Theodossiou; Donald Gantz; Efstratios Stratikos; Angeliki Chroni
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

4.  Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.

Authors:  Georgios Daniil; Vassilis I Zannis; Angeliki Chroni
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

5.  Mechanisms of amyloid-Beta Peptide uptake by neurons: the role of lipid rafts and lipid raft-associated proteins.

Authors:  Aaron Y Lai; Joanne McLaurin
Journal:  Int J Alzheimers Dis       Date:  2010-12-20

6.  Aβ internalization by neurons and glia.

Authors:  Amany Mohamed; Elena Posse de Chaves
Journal:  Int J Alzheimers Dis       Date:  2011-02-15

7.  The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific.

Authors:  Ioannis Dafnis; Letta Argyri; Marina Sagnou; Athina Tzinia; Effie C Tsilibary; Efstratios Stratikos; Angeliki Chroni
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

Review 8.  Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features.

Authors:  Irina Florina Tudorache; Violeta Georgeta Trusca; Anca Violeta Gafencu
Journal:  Comput Struct Biotechnol J       Date:  2017-06-06       Impact factor: 7.271

9.  Prophylaxis and treatment of Alzheimer's disease by delivery of an adeno-associated virus encoding a monoclonal antibody targeting the amyloid Beta protein.

Authors:  Masaru Shimada; Shinya Abe; Toru Takahashi; Kazumasa Shiozaki; Mitsue Okuda; Hiroaki Mizukami; Dennis M Klinman; Keiya Ozawa; Kenji Okuda
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

Review 10.  Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer's disease.

Authors:  Troy T Rohn
Journal:  Int J Mol Sci       Date:  2013-07-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.